<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pretto D</submitter><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><pagination>318</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4166380</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5</volume><pubmed_abstract>Expansions of more than 200 CGG repeats (full mutation) in the FMR1 gene give rise to fragile X syndrome (FXS) through a process that generally involves hypermethylation of the FMR1 promoter region and gene silencing, resulting in absence of expression of the encoded protein, FMRP. However, mosaicism with alleles differing in size and extent of methylation often exist within or between tissues of individuals with FXS. In the current work, CGG-repeat lengths and methylation status were assessed for eighteen individuals with FXS, including 13 mosaics, for which peripheral blood cells (PBMCs) and primary fibroblast cells were available. Our results show that for both PBMCs and fibroblasts, FMR1 mRNA and FMRP expression are directly correlated with the percent of methylation of the FMR1 allele</pubmed_abstract><journal>Frontiers in genetics</journal><pubmed_title>Clinical and molecular implications of mosaicism in FMR1 full mutations.</pubmed_title><pmcid>PMC4166380</pmcid><funding_grant_id>R01 HD040661</funding_grant_id><funding_grant_id>UL1 TR000002</funding_grant_id><funding_grant_id>P30 HD002274</funding_grant_id><pubmed_authors>Espinal G</pubmed_authors><pubmed_authors>Pretto D</pubmed_authors><pubmed_authors>Iwahashi CK</pubmed_authors><pubmed_authors>Tang HT</pubmed_authors><pubmed_authors>Yrigollen CM</pubmed_authors><pubmed_authors>Hagerman RJ</pubmed_authors><pubmed_authors>Williamson J</pubmed_authors><pubmed_authors>Hagerman PJ</pubmed_authors><pubmed_authors>Durbin-Johnson B</pubmed_authors><pubmed_authors>Tassone F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical and molecular implications of mosaicism in FMR1 full mutations.</name><description>Expansions of more than 200 CGG repeats (full mutation) in the FMR1 gene give rise to fragile X syndrome (FXS) through a process that generally involves hypermethylation of the FMR1 promoter region and gene silencing, resulting in absence of expression of the encoded protein, FMRP. However, mosaicism with alleles differing in size and extent of methylation often exist within or between tissues of individuals with FXS. In the current work, CGG-repeat lengths and methylation status were assessed for eighteen individuals with FXS, including 13 mosaics, for which peripheral blood cells (PBMCs) and primary fibroblast cells were available. Our results show that for both PBMCs and fibroblasts, FMR1 mRNA and FMRP expression are directly correlated with the percent of methylation of the FMR1 allele</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-03T22:55:28.004Z</modification><creation>2019-03-27T01:35:49Z</creation></dates><accession>S-EPMC4166380</accession><cross_references><pubmed>25278957</pubmed><doi>10.3389/fgene.2014.00318</doi></cross_references></HashMap>